MedCap Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for MedCap.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Life Sciences earnings growth | 46.4% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | None |
Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Estimating The Intrinsic Value Of MedCap AB (publ) (STO:MCAP)
Jun 06MedCap AB (publ) (STO:MCAP) Stocks Shoot Up 33% But Its P/E Still Looks Reasonable
May 21Should You Be Adding MedCap (STO:MCAP) To Your Watchlist Today?
May 04MedCap AB (publ)'s (STO:MCAP) P/E Is Still On The Mark Following 25% Share Price Bounce
Feb 15Is Now The Time To Put MedCap (STO:MCAP) On Your Watchlist?
Dec 21Do MedCap's (STO:MCAP) Earnings Warrant Your Attention?
May 06These 4 Measures Indicate That MedCap (STO:MCAP) Is Using Debt Safely
Nov 23We Ran A Stock Scan For Earnings Growth And MedCap (STO:MCAP) Passed With Ease
Sep 21Does MedCap (STO:MCAP) Deserve A Spot On Your Watchlist?
Apr 29MedCap (STO:MCAP) Seems To Use Debt Rather Sparingly
Feb 01Should You Be Adding MedCap (STO:MCAP) To Your Watchlist Today?
Aug 03Does MedCap (STO:MCAP) Have A Healthy Balance Sheet?
May 27Here's Why I Think MedCap (STO:MCAP) Is An Interesting Stock
Apr 07Imagine Holding MedCap (STO:MCAP) Shares While The Price Zoomed 558% Higher
Mar 15Have Insiders Been Selling MedCap AB (publ) (STO:MCAP) Shares?
Feb 26MedCap (STO:MCAP) Could Easily Take On More Debt
Feb 08Declining Stock and Solid Fundamentals: Is The Market Wrong About MedCap AB (publ) (STO:MCAP)?
Jan 22Should You Be Adding MedCap (STO:MCAP) To Your Watchlist Today?
Jan 07MedCap (STO:MCAP) Is Growing Earnings But Are They A Good Guide?
Dec 22If You Had Bought MedCap (STO:MCAP) Stock Five Years Ago, You Could Pocket A 663% Gain Today
Dec 08Are Insiders Selling MedCap AB (publ) (STO:MCAP) Stock?
Nov 23In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as MedCap has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
6/30/2024 | 1,753 | 214 | 244 | 299 | N/A |
3/31/2024 | 1,681 | 203 | 219 | 268 | N/A |
12/31/2023 | 1,600 | 172 | 189 | 228 | N/A |
9/30/2023 | 1,466 | 150 | 77 | 114 | N/A |
6/30/2023 | 1,343 | 149 | 61 | 97 | N/A |
3/31/2023 | 1,241 | 123 | 47 | 82 | N/A |
12/31/2022 | 1,124 | 118 | 41 | 86 | N/A |
9/30/2022 | 1,056 | 118 | 100 | 167 | N/A |
6/30/2022 | 1,017 | 107 | 78 | 146 | N/A |
3/31/2022 | 967 | 102 | 85 | 156 | N/A |
12/31/2021 | 926 | 97 | 55 | 116 | N/A |
9/30/2021 | 896 | 76 | 77 | 109 | N/A |
6/30/2021 | 869 | 64 | 60 | 90 | N/A |
3/31/2021 | 845 | 67 | 79 | 104 | N/A |
12/31/2020 | 828 | 63 | 91 | 115 | N/A |
9/30/2020 | 802 | 55 | 64 | 88 | N/A |
6/30/2020 | 786 | 53 | 75 | 101 | N/A |
3/31/2020 | 763 | 47 | 38 | 62 | N/A |
12/31/2019 | 757 | 55 | 41 | 71 | N/A |
9/30/2019 | 734 | 43 | 80 | 87 | N/A |
6/30/2019 | 740 | 41 | 70 | 107 | N/A |
3/31/2019 | 727 | 32 | 64 | 103 | N/A |
12/31/2018 | 709 | 24 | 56 | 91 | N/A |
9/30/2018 | 716 | 14 | 19 | 57 | N/A |
6/30/2018 | 689 | 8 | 13 | 27 | N/A |
3/31/2018 | 660 | 10 | N/A | 46 | N/A |
12/31/2017 | 617 | 7 | N/A | 41 | N/A |
10/31/2017 | 779 | 11 | N/A | 79 | N/A |
7/31/2017 | 802 | 3 | N/A | 85 | N/A |
4/30/2017 | 853 | 0 | N/A | 81 | N/A |
1/31/2017 | 901 | 5 | N/A | 32 | N/A |
10/31/2016 | 897 | 10 | N/A | -18 | N/A |
7/31/2016 | 874 | 19 | N/A | -44 | N/A |
4/30/2016 | 818 | 20 | N/A | -15 | N/A |
1/31/2016 | 817 | 18 | N/A | -60 | N/A |
10/31/2015 | 818 | 17 | N/A | -28 | N/A |
7/31/2015 | 825 | 8 | N/A | 14 | N/A |
4/30/2015 | 855 | 9 | N/A | 2 | N/A |
1/31/2015 | 891 | 9 | N/A | 50 | N/A |
10/31/2014 | 913 | 15 | N/A | 26 | N/A |
7/31/2014 | 910 | 21 | N/A | -1 | N/A |
4/30/2014 | 827 | 23 | N/A | 1 | N/A |
1/31/2014 | 651 | 18 | N/A | 29 | N/A |
10/31/2013 | 517 | 11 | N/A | 47 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if MCAP's forecast earnings growth is above the savings rate (1.1%).
Earnings vs Market: Insufficient data to determine if MCAP's earnings are forecast to grow faster than the Swedish market
High Growth Earnings: Insufficient data to determine if MCAP's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if MCAP's revenue is forecast to grow faster than the Swedish market.
High Growth Revenue: Insufficient data to determine if MCAP's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if MCAP's Return on Equity is forecast to be high in 3 years time